As detailed in The Highwire
video above, in January 2020, Dr. Julie Gerberding — director of the U.S.
Centers for Disease Control and Prevention from 2002 until 2009, who after
leaving the CDC became president of Merck’s vaccine division in January 20101 —
sold half her Merck stock options for $9.11 million.
Gerberding
also cashed in on her company stock options in 2016, when she sold $5.1
million-worth of Merck stocks, and 2015, when she made $2.3 million. In total,
Gerberding has made $16,592,144 from selling off her Merck stocks — all of
which, by the way, is over and beyond her regular paycheck — and she still owns
Merck stocks worth $9 million.
And
we’re supposed to believe she has been impartial about vaccine safety and has
been all along? As noted by Del Bigtree in his Highwire report:
“Do
you trust the information that come from your government agencies, when a year
after working [at] that agency, they move into the very company that they exonerated
from any wrongdoing and end up making $20-something-million dollars in stock
options, plus a gigantic salary? Sounds like a payoff to me.”
Quid Pro Quo
The payoff Bigtree is talking
about refers back to Gerberding’s exoneration of the MMR vaccine, which came
under fire when Dr. William Thompson, a CDC research scientist, blew the
whistle claiming the agency covered up a vaccine-autism connection in relation to the
MMR vaccine.
According
to Thompson, scientific fraud was committed for the express purpose of covering
up potential safety problems so the agency would be able to maintain that the
MMR vaccine had been proven safe to give to all children.
Thompson explained they
simply eliminated the incriminating data, thereby vanishing the link, and this
cover-up occurred while Gerberding headed up the CDC. The CDC subsequently
also blocked a request for Thompson to testify in
an autism lawsuit.
Indeed,
you’d have to be really naïve not to see the enormous influence her former
high-level ties to the CDC can have, considering Merck makes a majority of the
pediatric and adults vaccines recommended by the CDC.
The
vaccine industry is booming, and it’s become quite clear that profit potential
is the driving factor behind it. One of the reasons for this is because vaccine
patents do not expire like drugs do, so each vaccine adopted for widespread use
has the potential to make enormous, continuous profits for decades to come.
Vaccine
makers also enjoy a high degree of immunity against lawsuits — and in the case
of pandemic vaccines, absolute immunity — so the financial liability when
something goes wrong is exceptionally low, compared to drugs.
HPV Vaccine Responsible for
Massive Rise in Cervical Cancer?
An article2 by
Robert F. Kennedy, chairman of the Children’s Health Defense, wonders whether
Gerberding’s stock dump might have anything to do with recent red flags being
raised about Merck’s HPV vaccine Gardasil. He writes:3
“Last
month, Cancer Research UK announced4,5,6 an
alarming 54% rise in cervical cancer among 24-29-year-olds, the first
generation to receive the HPV jabs.
The
following day, the Journal of the Royal Society of Medicine published7 a
withering critique of Gardasil’s crooked clinical trials, ‘It is still
uncertain whether human papillomavirus (HPV) vaccination prevents cervical
cancer as trials were not designed to detect this outcome.’
As
Gerberding knows, those trials8 revealed
that Gardasil dramatically RAISES (by +44.6%) the risk of cervical cancer among
women with a current infection or those previously exposed to HPV.
That
may explain the cancer explosions in England and other nations with high
inoculation rates in young girls up to age 18; Australia, Spain, Sweden and
Norway. A 2019 study9 of Alabama girls found
the highest cervical cancer rates in the state’s most heavily vaccinated
counties.
With
Merck’s efficacy pretensions circling the drain, a coalition of leading
plaintiff’s lawyers are already in discovery in a suit10 alleging
that Merck fraudulently concealed serious illnesses affecting half, and
autoimmune diseases affecting 1 of every 37 girls in Gardasil’s clinical trials
within 6 months of injection.
As
Centers for Disease Control (CDC) Director from 2002-2009, Gerberding helped
Merck paper over these efficacy and safety problems.”
Chances are, Gerberding’s
2004 report to Congress, “Prevention of Genital Human Papillomavirus
Infection,”11 played a significant role in getting the controversial HPV
vaccine fast tracked to licensure by the FDA in the first place. Needless to
say, the approval of this questionable vaccine guaranteed her future employer
billions of dollars-worth of profits.
Gerberding has also been a
staunch defender of thimerosal, the mercury-based vaccine preservative
suspected of being one of vaccine ingredients involved in the development of
autism in some children. Thimerosal was removed from childhood vaccines or
reduced to trace amounts between 1999 and 2001, with the exception of multidose
influenza vaccines.12
Fat for Fuel: A Revolu...Dr.
Joseph MercolaBest Price: $7.40Buy New $11.89(as
of 10:20 EST - Details)
Since then, there have been a
number of additional biological mechanisms proposed by independent researchers
investigating why vaccines cause harm.13
The use of aluminum in vaccines, for example, may cause
neurological damage. In The Highwire video, Gerberding herself was in 2008
forced to admit that children with an underlying mitochondrial disorder are at increased risk for vaccine
damage.
Gerberding’s admission came
after Hannah Poling, who developed autism after her
18-month well-baby visit when she received nine vaccines, was granted
compensation by the U.S. Division of Vaccine Injury Compensation for her
injuries.
All
in all, Gerberding has repeatedly demonstrated that safety is nowhere on her
list of priorities or concerns when it comes to vaccines, so it’s easy to see
why Merck would want her to head up their vaccine unit.
HPV Maker’s Role in Vaccination
Policymaking
A 2012 article14 in
the American Journal of Public Health, in which the authors investigated the
role Merck played in state HPV immunization policymaking, states that:
“Merck
promoted school-entry mandate legislation by serving as an information
resource, lobbying legislators, drafting legislation, mobilizing female
legislators and physician organizations, conducting consumer marketing
campaigns, and filling gaps in access to the vaccine.
Legislators
relied heavily on Merck for scientific information. Most stakeholders found
lobbying by vaccine manufacturers acceptable in principle, but perceived that
Merck had acted too aggressively and nontransparently in this case.
Although
policymakers acknowledge the utility of manufacturers’ involvement in
vaccination policymaking, industry lobbying that is overly aggressive, not
fully transparent, or not divorced from financial contributions to lawmakers
risks undermining the prospects for legislation to foster uptake of new
vaccines.”
Merck Plays Loose With HPV
Vaccine Data
In June 2019, I
published Kennedy’s presentation of Merck’s clinical trial data for
Gardasil, in which he reveals how the company hid the truth about
its side effects. One way in which Merck committed fraud in its Gardasil
vaccine safety trials was by using a neurotoxic ingredient in Gardasil as a
bioactive placebo. This trick effectively renders its safety testing null and
void, as the true extent of harm cannot be ascertained.
Merck’s
own trial data also reveals Gardasil increases the overall risk of death by
370%, the risk of autoimmune disease by 2.3% and the risk of a serious medical
condition by 50%.
Kennedy also points out that
National Cancer Institute data show the mortality rate for cervical cancer is 1 in 43,478 (2.3 per
100,000), and the median age of cervical cancer death is 58. To eliminate that
one death, all 43,478 must pay $420 — the average cost of the three Gardasil
injections.
According
to Kennedy, 76 million American children have been mandated by the U.S. Centers
for Disease Control and Prevention to receive the vaccine, providing Merck with
an annual revenue of $2.3 billion. When you crunch the numbers, you realize
that the cost of using Gardasil to save one life is $18.3 million.
Meanwhile,
compensation paid by the Vaccine Court for the death of a child maxes out at
$250,000. Put another way, $18.3 million is being spent in an effort to save
one life from a disease, while the U.S. Health and Human Services values human
life at just a quarter of a million dollars per person when a person dies from
using a government recommended vaccine in that effort.
If
you’re still on the fence when it comes to HPV vaccination, you owe it to
yourself to watch Kennedy’s presentation and conduct additional research on the
vaccine and HPV so that you can appropriately weigh the risks and benefits.
One of the Most Powerful Videos
I’ve Ever Seen
The
following video from Barbara Loe Fisher is one of the most powerful videos that
I have ever seen. I am hopeful that watching this video will inspire you to
take up the cause and join the fight for vaccine freedom and independence.
There
is a cultural war and collusion between many industries and federal regulatory
agencies that results in a suppression of the truth about vital important
health issues. If this suppression continues we will gradually and
progressively erode our private individual rights that our ancestors fought so
hard to achieve. Please take a few minutes to watch this video.
Protect Your Right to Informed
Consent and Defend Vaccine Exemptions
KetoFast: Rejuvenate Y...Mercola,
Dr. JosephCheck Amazon for Pricing.
With all the uncertainty
surrounding the safety and efficacy of vaccines, it’s critical to protect your
right to make independent health choices and exercise voluntary informed
consent to vaccination. It is urgent that everyone in America stand up and
fight to protect and expand vaccine informed consent protections in state
public health and employment laws. The best way to do this is to get personally
involved with your state legislators and educate the leaders in your community.
Think Globally, Act Locally
National
vaccine policy recommendations are made at the federal level but vaccine laws
are made at the state level. It is at the state level where your action to
protect your vaccine choice rights can have the greatest impact.
It is
critical for EVERYONE to get involved now in standing up for the legal right to
make voluntary vaccine choices in America because those choices are being
threatened by lobbyists representing drug companies, medical trade associations
and public health officials, who are trying to persuade legislators to strip
all vaccine exemptions from public health laws.
Signing up for NVIC’s free
Advocacy Portal at www.NVICAdvocacy.org gives you immediate,
easy access to your own state legislators on your smartphone or computer so you
can make your voice heard. You will be kept up to date on the latest state
bills threatening your vaccine choice rights and will get practical, useful
information to help you become an effective vaccine choice advocate in your own
community.
Also,
when national vaccine issues come up, you will have the up-to-date information
and call-to-action items you need at your fingertips. So, please, as your first
step, sign up for the NVIC Advocacy Portal.
Sources and References
- 1 Science Magazine December 22,
2009
- 2, 3 Namely Liberty February 5,
2020
- 4 Cancer Research UK January 22,
2020
- 5 Independent January 22, 2020
- 6 Children’s Health Defense
January 23, 2020
- 7 Journal of the Royal Society
of Medicine January 21, 2020
- 8 Gardasil HPV Quadrivalent
Vaccine, May 18, 2006 VRBPAC Meeting (PDF)
- 9 Alabama News Center March 24,
2019
- 10 Helenlobato.com March 20, 2019
- 11 REPORT TO CONGRESS, Prevention of Genital Human
Papillomavirus Infection (PDF)
- 12 CDC.gov, Thimerosal in
Vaccines
- 13 Chiropractic.org, Truth Will
Prevail: 1200 Studies That Refute Vaccine Claims (PDF)
- 14 American Journal of Public
Health 2012 May; 102(5): 893–898
Copyright © Dr. Joseph Mercola
